The optimal therapeutic strategy for locally advanced pancreatic cancer patients (LAPC) has not yet been established. Our aim is to evaluate how surgery after neoadjuvant treatment with either FOLFIRINOX (FFN) or Gemcitabine-NabPaclitaxel (GemNab) affects the clinical outcome in these patients. LAPC patients treated at our institution were retrospectively analysed to reach this goal. The group characteristics were similar: 35 patients were treated with the FOLFIRINOX regimen and 21 patients with Gemcitabine Nab-Paclitaxel. The number of patients undergoing surgery was 14 in the FFN group (40%) and six in the GemNab group (28.6%). The median Disease-Free Survival (DFS) was 77.10 weeks in the FFN group and 58.65 weeks in the Gem Nab group ( = 0.625), while the median PFS in the unresected group was 49.4 weeks in the FFN group and 30.9 in the GemNab group ( = 0.0029, 95% CI 0.138-0.862, HR 0.345). The overall survival (OS) in the resected population needs a longer follow up to be completely assessed, while the median overall survival (mOS) in the FFN group was 72.10 weeks and 53.30 weeks for the GemNab group ( = 0.06) in the unresected population. Surgery is a valuable option for LAPC patients and it is able to induce a relevant survival advantage. FOLFIRINOX and Gem-NabPaclitaxel should be offered as first options to pancreatic cancer patients in the locally advanced setting.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678351 | PMC |
http://dx.doi.org/10.3390/cancers11070981 | DOI Listing |
Healthcare (Basel)
October 2024
Neuroscience Research Australia, Sydney, NSW 2031, Australia.
PLoS One
September 2024
Department of Information and Communication Technologies, Centre for Artificial Intelligence Research (CAIR), University of Agder, Grimstad, Norway.
Deep learning-based models for predicting blood glucose levels in diabetic patients can facilitate proactive measures to prevent critical events and are essential for closed-loop control therapy systems. However, selecting appropriate models from the literature may not always yield conclusive results, as the choice could be influenced by biases or misleading evaluations stemming from different methodologies, datasets, and preprocessing techniques. This study aims to compare and comprehensively analyze the performance of various deep learning models across diverse datasets to assess their applicability and generalizability across a broader spectrum of scenarios.
View Article and Find Full Text PDFAm J Perinatol
December 2024
Department of Obstetrics & Gynecology, Kaiser Permanente West Los Angeles Medical Center, Los Angeles, California.
Objective: Fetal fibronectin (fFN) testing and transvaginal ultrasound (TVUS) are diagnostic tools used to predict impending spontaneous preterm birth (sPTB) among women presenting with preterm labor (PTL). We evaluated the association between fFN testing or TVUS cervical length (CL) measurement in predicting sPTB, respiratory distress syndrome (RDS), neonatal intensive care unit (NICU) admission, and sPTB-related costs.
Study Design: We conducted a retrospective cohort study using data from the Kaiser Permanente Southern California electronic health system (January 1, 2009-December 31, 2020) using diagnostic and procedure codes, along with a natural language processing algorithm to identify pregnancies with PTL evaluations.
Front Sports Act Living
February 2024
Laboratoire MOVE (UR 20296), Faculté des Sciences du Sport, Université de Poitiers, Poitiers, France.
Introduction: In swimming, performance gains after tapering could be influenced by the pre-taper level of fatigue. Moreover, this level of fatigue could be associated with sleep. This study aimed to assess (1) the effect of tapering on performance according to the pre-taper level of fatigue in swimmers and (2) the association between sleep and pre-taper level of fatigue.
View Article and Find Full Text PDFAnn Biol Clin (Paris)
February 2024
Department of Hormonology, Metabolism, Nutrition and Oncology, University Hospital of Lille, Lille, France.
The recreational use of nitrous oxide (N2O) is an emerging public health issue. Chronic N2O abuse may result in various clinical symptoms, encompassing neurological, psychiatric and cardiovascular outcomes. Despite the difficulties for the laboratory investigation of N2O intoxication, there is currently no guidelines in France to help both clinicians and biologists use appropriate biomarkers for the diagnosis and monitoring of patients with clinical symptoms potentially related to N2O intoxication.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!